Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Mesa Laboratories, Inc. (MLAB : NSDQ)

• Company Description    MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. Number of Employees: 730

• Price / Volume Information    Yesterday's Closing Price: $63.09 Daily Weekly Monthly 20 Day Moving Average: 108,700 shares Shares Outstanding: 5.50 (millions) Market Capitalization: $347.09 (millions) Beta: 0.82 52 Week High: $155.12 52 Week Low: $55.45 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -7.07% -8.75% 12 Week -32.15% -38.40% Year To Date -52.16% -57.28%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 12100 W 6TH AVE - LAKEWOOD,CO 80228 USA ph: 303-987-8000 fax: 303-987-8989 investorrelations@mesalabs.com http://www.mesalabs.com

• General Corporate Information    Officers Gary M. Owens - Chief Executive Officer; President; and Director John J. Sullivan - Chairman of the Board of Directors John V. Sakys - Chief Financial Officer and Chief Accounting Offic Jennifer S. Alltoft - Director Mark C. Capone - Director Peer Information Mesa Laboratories, Inc. (ABMD) Mesa Laboratories, Inc. (DMDS) Mesa Laboratories, Inc. (CPWY.) Mesa Laboratories, Inc. (EQUR) Mesa Laboratories, Inc. (ECIA) Mesa Laboratories, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 59064R109 SIC: 3823 Fiscal Year Fiscal Year End: March Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/06/25 Share - Related Items Shares Outstanding: 5.50 Most Recent Split Date: (:1) Beta: 0.82 Market Capitalization: $347.09 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 1.01% Current Fiscal Quarter EPS Consensus Estimate: $1.97 Indicated Annual Dividend: $0.64 Current Fiscal Year EPS Consensus Estimate: $8.09 Payout Ratio: 0.09 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: -0.02 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 08/29/2025 - $0.16 Next EPS Report Date: 11/06/25

• Fundamental Ratios P/E Current FY Estimate: 7.80 Trailing 12 Months: 8.82 PEG Ratio: - Price Ratios Price/Book: 2.01 Price/Cash Flow: 5.15 Price / Sales: 1.43 EPS Growth vs. Year Ago Period: -29.26% vs. Previous Quarter: -1.82% Sales Growth vs. Year Ago Period: 2.36% vs. Previous Quarter: -4.17% ROE 06/30/25 - 24.49 03/31/25 - 27.51 12/31/24 - 30.23 ROA 06/30/25 - 9.03 03/31/25 - 9.78 12/31/24 - 10.42 Current Ratio 06/30/25 - 0.66 03/31/25 - 0.63 12/31/24 - 0.71 Quick Ratio 06/30/25 - 0.47 03/31/25 - 0.47 12/31/24 - 0.53 Operating Margin 06/30/25 - 16.40 03/31/25 - 17.90 12/31/24 - 19.48 Net Margin 06/30/25 - -0.26 03/31/25 - -0.82 12/31/24 - -104.92 Pre-Tax Margin 06/30/25 - 3.74 03/31/25 - 2.47 12/31/24 - -113.50 Book Value 06/30/25 - 31.35 03/31/25 - 29.42 12/31/24 - 28.57 Inventory Turnover 06/30/25 - 3.30 03/31/25 - 3.13 12/31/24 - 2.90 Debt-to-Equity 06/30/25 - 0.46 03/31/25 - 0.48 12/31/24 - 0.61 Debt-to-Capital 06/30/25 - 31.56 03/31/25 - 32.49 12/31/24 - 37.92

Powered by Zacks Investment Research ©